Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • NPI Medicare & Medicaid
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.28
    OpenPayerBilling CodesDiseases and Disorders of the Digestive SystemDRG 368-major-esophageal-disorders-with-mcc
    Ask Trek AI about this page

    Major Esophageal Disorders with MCC: Inpatient Reimbursement Overview

    DRG 368 addresses major esophageal disorders with a Major Complication or Comorbidity and encompasses high-severity clinical scenarios that often require complex surgical or intensive medical management. This Diagnosis-Related Group matters for inpatient reimbursement because the Major Complication or Comorbidity designation increases the payment weight to account for greater expected resource use.

    Customize your policy alerts

    Sign up for drg 368 policy alerts

    Get alerted when payer policies referencing 368 are released or updated.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    DRG 368 Overview

    DRG 368 covers hospital inpatient cases for major esophageal disorders with a Major Complication or Comorbidity present, including severe motility disorders, complex perforations, and advanced ischemic or necrotic processes of the esophagus. This Diagnosis-Related Group groups higher-severity esophageal conditions that drive increased resource use, longer lengths of stay, and more intensive procedures or postoperative care. It matters for Medicare payment because the presence of a Major Complication or Comorbidity increases the relative weight and reimbursement compared with lower-severity esophageal Diagnosis-Related Groups. Accurate coding of the primary diagnosis and comorbidities is essential to reflect expected resource consumption under Medicare inpatient payment policies.

    Table of contents

    Progress1 / 3

    Explore openpayer tools

    • Billing CodesCPT, HCPCS, DRG & more
    • Reimbursement RatesCommercial vs. Medicare rate reports
    • ProvidersHospitals & facilities
    • PayersPlans & market footprint
    • Taxonomy CodesNUCC specialty codes
    • ModifiersCPT modifiers & usage
    • Prior AuthorizationPA policies by payer & drug
    • Timely FilingFiling deadlines by payer
    • Coverage CriteriaMedical necessity by payer
    • Payer ContactsClaims, PA & appeals contacts
    View all tools

    Clinical Trials

    • Acute surgical and perioperative intervention trials: randomized or prospective cohort studies evaluating timing, technique, and perioperative management for patients with major esophageal disorders (such as advanced achalasia, severe strictures, perforation, or ischemia) who require urgent or elective esophagectomy, esophageal reconstruction, or endoscopic full‑thickness interventions. These studies focus on intraoperative approaches, anesthesia strategies, blood loss and transfusion thresholds, and immediate postoperative complications (anastomotic leak, respiratory failure, sepsis) in a high‑acuity inpatient population. Results inform operative risk stratification, protocols to reduce intensive care utilization, and short‑term cost drivers that are highly relevant to hospital reimbursement and DRG resource planning.
    • Comparative effectiveness and device/technique trials in definitive or complication management: multicenter comparative studies (randomized where feasible or propensity‑matched observational studies) comparing endoscopic versus open surgical approaches, different stenting technologies or reconstruction techniques, and enhanced recovery pathways for patients with complex benign or malignant esophageal disease complicated by comorbidities. The patient populations include medically complex older adults and those with major complications (MCC) whose outcomes (length of stay, readmission, need for reoperation, and complication rates) directly affect case mix index and payer reimbursements. Findings help providers choose approaches that balance clinical effectiveness with resource utilization and inform payer coverage decisions for higher‑cost technologies.
    • Post‑discharge outcomes and care‑coordination research: prospective cohort and quality improvement studies assessing transitional care interventions, home health utilization, nutritional rehabilitation, and long‑term functional outcomes (swallowing function, quality of life, and rehospitalization) in survivors of major esophageal procedures or complications. These studies target patients discharged after extended inpatient stays with complex needs (feeding tubes, tracheostomy, chronic wounds) to identify strategies that reduce readmissions, durable medical equipment use, and downstream costs. Evidence from this research guides case management protocols, bundled payment models, and payer strategies to improve outcomes while controlling post‑acute expenditures.

    Related Codes

    326-STOMACH-ESOPHAGEAL-AND-DUODENAL-PROCEDURES-WITH-MCC

    Stomach, Esophageal and Duodenal Procedures with MCC: Inpatient Reimbursement Overview

    327-STOMACH-ESOPHAGEAL-AND-DUODENAL-PROCEDURES-WITH-CC

    Stomach, Esophageal and Duodenal Procedures with CC: Inpatient Reimbursement Overview

    328-STOMACH-ESOPHAGEAL-AND-DUODENAL-PROCEDURES-WITHOUT-CC-MCC

    Stomach, Esophageal and Duodenal Procedures without CC/MCC: Inpatient Reimbursement Overview

    329-MAJOR-SMALL-AND-LARGE-BOWEL-PROCEDURES-WITH-MCC

    Major Small and Large Bowel Procedures with MCC: Inpatient Reimbursement Overview

    330-MAJOR-SMALL-AND-LARGE-BOWEL-PROCEDURES-WITH-CC

    Major Small and Large Bowel Procedures with CC: Inpatient Reimbursement Overview

    331-MAJOR-SMALL-AND-LARGE-BOWEL-PROCEDURES-WITHOUT-CC-MCC

    Major Small and Large Bowel Procedures without CC/MCC: Inpatient Reimbursement Overview

    332-RECTAL-RESECTION-WITH-MCC

    Rectal Resection with MCC: Inpatient Reimbursement Overview

    333-RECTAL-RESECTION-WITH-CC

    Rectal Resection with CC: Inpatient Reimbursement Overview

    334-RECTAL-RESECTION-WITHOUT-CC-MCC

    Rectal Resection without CC/MCC: Inpatient Reimbursement Overview

    335-PERITONEAL-ADHESIOLYSIS-WITH-MCC

    Peritoneal Adhesiolysis with MCC: Inpatient Reimbursement Overview

    Showing 1–10 of 57

    References

    1. 1.CPT® Codes and Descriptions. AAPC. Retrieved Aug 11, 2026.Maintains the CPT code set's official descriptions and guidelines, licensed from the American Medical Association, used as the definitional source for CPT codes on this page.
    2. 2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's quarterly release of HCPCS Level II codes and short/long descriptors, the source for HCPCS code definitions and update history.
    3. 3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's complete ICD-10-CM diagnosis code list, used to cross-reference diagnosis codes associated with this procedure or service.
    Published by

    Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

    Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.